Vincent Leroy, Peter Angus, Jean-Pierre Bronowicki, Gregory J. Dore, Christophe Hezode, et al.. Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).
Hepatology, Wiley-Blackwell, 2016, 63 (5), pp.1430-1441.
⟨10.1002/hep.28473⟩.
⟨hal-01659112⟩